Cyclophosphamide plus rituximab appears effective in refractory thrombotic thrombocytopenic purpura

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1378, 2003-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

標準治療抵抗性の血栓性血小板減少性紫斑病に対するリツキシマブ投与のタイミングについての考察(Optimal timing of rituximab administration for refractory thrombotic thrombocytopenic purpura: a retrospective case series)

By  

NIHON KYUKYU IGAKUKAI ZASSHI: JOURNAL OF JAPANESE ASSOCIATION FOR ACUTE MEDICINE, Vol. 26, Iss. 6, 2015-06 ,pp. : 152-159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunosuppressive therapy appears beneficial in recurrent thrombotic thrombocytopenic purpura

By  

Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Clopidogrel linked with thrombotic thrombocytopenic purpura

By  

Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Investigational drugs in thrombotic thrombocytopenic purpura

By Noris Patrizia   Balduini Carlo L  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1087-1098

Informa Healthcare

Access to resources Recommend Favorite

Rifampicin: Thrombotic thrombocytopenic purpura: case report

By  

Reactions Weekly, Vol. 1, Iss. 1081, 2005-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite